| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ADD3
|
adducin 3 (gamma)
|
|
AGR2
|
anterior gradient 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
APCS
|
amyloid P component, serum
|
|
APOE
|
apolipoprotein E
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
ARTN
|
artemin
|
|
ATF2
|
activating transcription factor 2
|
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
|
|
B3GALT5
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAX
|
BCL2-associated X protein
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCAR3
|
breast cancer anti-estrogen resistance 3
|
|
BCAR4
|
breast cancer anti-estrogen resistance 4 (non-protein coding)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRCA1
|
breast cancer 1, early onset
|
|
C3
|
complement component 3
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CARM1
|
coactivator-associated arginine methyltransferase 1
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCNA2
|
cyclin A2
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CDC25B
|
cell division cycle 25B
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CKB
|
creatine kinase, brain
|
|
CNOT1
|
CCR4-NOT transcription complex, subunit 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DEK
|
DEK proto-oncogene
|
|
DHX30
|
DEAH (Asp-Glu-Ala-His) box helicase 30
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
E2F1
|
E2F transcription factor 1
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EP300
|
E1A binding protein p300
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ESRRG
|
estrogen-related receptor gamma
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2
|
coagulation factor II (thrombin)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FKBPL
|
FK506 binding protein like
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXA1
|
forkhead box A1
|
|
FOXL2
|
forkhead box L2
|
|
FOXM1
|
forkhead box M1
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
GATA3
|
GATA binding protein 3
|
|
GDF15
|
growth differentiation factor 15
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GH1
|
growth hormone 1
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPS2
|
G protein pathway suppressor 2
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTA2
|
glutathione S-transferase alpha 2
|
|
GSTA3
|
glutathione S-transferase alpha 3
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC4
|
histone deacetylase 4
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPAB
|
heterogeneous nuclear ribonucleoprotein A/B
|
|
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H)
|
|
HNRNPH2
|
heterogeneous nuclear ribonucleoprotein H2 (H')
|
|
HNRNPH3
|
heterogeneous nuclear ribonucleoprotein H3 (2H9)
|
|
HRG
|
histidine-rich glycoprotein
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IL1B
|
interleukin 1, beta
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
ILK
|
integrin-linked kinase
|
|
JUN
|
jun proto-oncogene
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNMB1
|
potassium channel subfamily M regulatory beta subunit 1
|
|
KLRC3
|
killer cell lectin-like receptor subfamily C, member 3
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
LIF
|
leukemia inhibitory factor
|
|
LIPC
|
lipase, hepatic
|
|
LPL
|
lipoprotein lipase
|
|
LTF
|
lactotransferrin
|
|
MAP1LC3B
|
microtubule-associated protein 1 light chain 3 beta
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBP
|
myelin basic protein
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM6
|
minichromosome maintenance complex component 6
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH10
|
myosin, heavy chain 10, non-muscle
|
|
MYO5A
|
myosin VA (heavy chain 12, myoxin)
|
|
NANS
|
N-acetylneuraminic acid synthase
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOA6
|
nuclear receptor coactivator 6
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NELFB
|
negative elongation factor complex member B
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIB
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
|
|
NOA1
|
nitric oxide associated 1
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2F1
|
nuclear receptor subfamily 2, group F, member 1
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRIP1
|
nuclear receptor interacting protein 1
|
|
OXCT1
|
3-oxoacid CoA transferase 1
|
|
OXTR
|
oxytocin receptor
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PGR
|
progesterone receptor
|
|
PHB2
|
prohibitin 2
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PLG
|
plasminogen
|
|
PLK1
|
polo-like kinase 1
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRL
|
prolactin
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROS1
|
protein S (alpha)
|
|
PSMA1
|
proteasome (prosome, macropain) subunit, alpha type, 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O
|
|
RAD51
|
RAD51 recombinase
|
|
RB1
|
retinoblastoma 1
|
|
RBL1
|
retinoblastoma-like 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBM17
|
RNA binding motif protein 17
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RORA
|
RAR-related orphan receptor A
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
SERPINA7
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SHBG
|
sex hormone-binding globulin
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SST
|
somatostatin
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
SULT2A1
|
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
|
|
TBX21
|
T-box 21
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFF1
|
trefoil factor 1
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TLE3
|
transducin-like enhancer of split 3
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TRRAP
|
transformation/transcription domain-associated protein
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
UGT1A4
|
UDP glucuronosyltransferase 1 family, polypeptide A4
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VWF
|
von Willebrand factor
|
|
WT1
|
Wilms tumor 1
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
